The Maxima is a new breathing system which makes it possible to monitor cardiac output (Q
. ) noninvasively and to follow trends continuously. When used as a rebreathing system in controlled ventilation, the Maxima selectively eliminates alveolar gas and no fresh gas (V . F) is eliminated. Without the need for a mixing chamber, eliminated CO 2 (FE -CO 2 ) may be measured directly. With steady state conditions, and assuming a respiratory quotient of 1, carbon dioxide production (V . CO F was adjusted to achieve an FE -CO 2 value of approximately 4.1%. Cardiac output estimates were compared with those obtained using a thermodilution technique in five patients undergoing coronary artery bypass grafting and in four patients with septicaemia in the ICU. Cardiac outputs were estimated from 1. V . CO 2 measurements and then 2. V . CO 2 and haemoglobin (Hb) . The result of 28 measurements on nine patients with methods 1. and 2. respectively yielded a correlation with thermodilution measurements: coefficient r = 0.91 and 0.94 with a bias of -10.5% and -0.05% and an accuracy of 14% and 9%.
Under steady state conditions, blood that flows through the lungs offloads carbon dioxide into alveoli at a rate that is dependent upon pulmonary blood flow (Q . ) . In steady state conditions, Q . needs to be matched by an effective alveolar ventilation (V . Ae), which under conditions of mild hypocarbia to normocarbia, results in a ratio of Q . :V . Ae which is approximately equal to 1. If Q . and V . Ae are not matched, the respiratory quotient (R) changes and one cannot claim the presence of a steady state. The Maxima breathing system is a recently described, valveless, disposable, universal breathing system 1 which selectively eliminates alveolar gas. When used as a rebreathing system in controlled ventilation, it is shown that V . Ae = V . F 2 . This characteristic lends itself to the possibility of obtaining a continuous estimate of cardiac output.
A simple means for the noninvasive measurement of cardiac output has been an elusive goal for many years. Most measurements of cardiac output have been based on the Fick principle. Its application to CO 2 exchange in exercise physiology is well known, where rebreathing techniques are used to obtain an estimate of pulmonary arterial CO 2 , and end-tidal CO 2 is used as an estimate of pulmonary venous CO 2 . Unfortunately, the assumption that end-tidal CO 2 is a good estimate of pulmonary venous CO 2 is unacceptable for clinical use in general, as alveolar deadspace (parallel deadspace), which may vary enormously between patients, dilutes the end-tidal CO 2 value 3,4 . This has necessitated the sampling of arterial blood to obtain P a CO 2 as the estimate of pulmonary venous CO 2 . If the arterial-to-venous CO 2 content difference and the carbon dioxide production (V . CO 2 ) are known, cardiac output (Q . ) can be calculated 5, 6 . As arterial blood gas analysis is needed, the method is still somewhat invasive. This pilot study attempts to look at the contribution in determining Q . of two of the three components in the indirect Fick method applied to CO 2 exchange. The three major variables are V . CO 2 , P a CO 2 -P v CO 2 and haemoglobin (Hb). The latter two variables determine the arterial-to-venous PCO 2 content difference (C a CO 2 -C v CO 2 ). The relation between these variables is given by: Q . = V . CO 2 /(C a CO 2 -C v CO 2 ) -Eq. 1 Of the two components which determine C a CO 2 -C v CO 2 , namely P a CO 2 -P v CO 2 and Hb, Hb is the simplest to measure. Haemoglobin is important because of the carbamino carriage of CO 2 , the Haldane effect, and for a given P a CO 2 -P v CO 2 , its value determines directly the pulmonary arterial-tovenous CO 2 content difference 7 .
METHODS
Permission for this pilot study was granted by the Hospital Ethics Committee and informed consent was obtained from each patient. Patients who were to undergo coronary artery bypass graft operations and who were to be monitored by means of a thermodilution catheter were selected for the measurement of the lower range of cardiac output. For the higher range of cardiac output, patients were selected who had septicaemia, were being ventilated in the intensive care unit and who were already being monitored by means of a thermodilution catheter.
The cardiac output was measured by the thermodilution technique using a flow-directed balloon tip triple-lumen catheter (Swan-Ganz, Baxter Edwards Critical-Care, Irvine CA) floated into the pulmonary artery. To obtain accurate and reproducible thermodilution measurements 8 , 5% dextrose 10 ml at room temperature was injected at the beginning of the expiratory phase of the respiratory cycle. The mean value of three sequential cardiac output measurements (coefficient of variation <10%) was taken as a representative value. In the case of the five heart surgery patients the measurements were limited to the period prior to the initiation of cardiopulmonary bypass.
A dedicated anaesthesia machine was used for the study. The flowmeters were calibrated using a RT200 Timeter calibration analyser. Adequacy of ventilation in relation to fresh gas flow was ensured by observing a rebreathing pattern of CO 2 in the endotracheal tube (A) and at the outlet of the breathing system (B), the latter being the most important ( Figure 2 ) and characterized by a less than 0.4% variation in CO 2 (usually 0.2-0.1%). The V . F was adjusted to achieve a mean eliminated CO 2 (FE -CO 2 ) value of 4.0%-4.2%. The actual value was not as important as the need for the value to remain at a constant level, reflecting what we termed an "acute steady state". The small linear adjustment of the actual value back to the 4.1% level could then be made. Precision values for a true mean FE -CO 2 were obtained by the use of a computer with analog-to-digital interface to access the analog signal from a Datex Cardiocap I monitor which was used for the study. A Datex Safe + Sure calibration mixture, comprising 5% CO 2 , 55% O 2 and 40% N 2 O was used to calibrate the capnograph. The CO 2 sampling rate was 150 ml.min -1 .
Values for the two cardiac output methods being tested, Q1 and Q2, were calculated from the mean of two measured values of V . F and FE -CO 2 . These were obtained immediately before and after thermodilution measurements.
For explanation of methods 1, 2 and 3 see theory below:
Theory
The property of the selective elimination of alveolar gas in a breathing system results in the exhaust/efferent limb of the system comprising alveolar gas. Alveolar concentration of carbon dioxide varies during normal tidal ventilation by approximately 0.4% (Figure 1) .
What is eliminated via the efferent limb of the Maxima system therefore may also vary by a similar magnitude. However, by sampling distally as shown in Figure 2 , carbon dioxide concentrations with even less variation are likely. It is well known that alveolar CO 2 = V . CO 
The mean C a CO 2 -C v CO 2 in patients with a normal haemoglobin (taken to be 13.33 g.dl -1 ) is approximately 4 volumes per cent 7, 9 and in this study was estimated at 4.1 ml.dl -1 . Therefore, if V . F supply into the Maxima system is adjusted to give a value of FE -CO 2 = 4.1% or kPa at sea level, then from equation 3., Q . = V . F as FE -CO 2 /C a CO 2 -C v CO 2 = 1.
The cardiac output obtained by this method would be based on V . CO 2 alone and provides us with the first series of estimates.
The influence of haemoglobin (Hb) upon pulmonary venous to arterial CO 2 content difference is almost linear 7 . Also, it is observed that for a haemoglobin of 13.33 g.dl -1 applied to Hb that is 100% saturated with oxygen (O 2 ), for a CO 2 content difference of 4 ml.dl -1 , 50% of the content difference is based upon Hb carbamino carriage and 50% on the plasma carriage of CO 2 7 . However, we are in fact dealing with a situation where pulmonary arterial blood is desaturated and the venous component saturated. To illustrate the difference this makes, therefore, and based on McHardy's work using Visser's equation 10 , the relation of the partial pressure difference to content (P a CO 2 -P v CO 2 to C a CO 2 -C v CO 2 ) has been summarized in we can see that for a CO 2 content difference of 4 ml.dl -1 , the PCO 2 difference is not 1.3 as for the line for saturated Hb but only 0.44 (about one third of the former) according to the 70% desaturated pulmonary arterial to saturated venous blood line. The CO 2 content difference which can be attributed to plasma carriage of CO 2 is therefore only about one sixth of the total. The contribution of a Hb of 13.33 g.dl -1 to the CO 2 content difference, therefore, is 83% and the contribution of plasma is only 17%.
If it is assumed that homeostatic mechanisms in the body would tend to adjust cardiac output so as to achieve a constant pulmonary venous-to-arterial PCO 2 difference (the third component), then haemoglobin would be the second most important of the three components in the indirect Fick equation. Cardiac output estimate using Hb in the calculation constitutes the second series and Q . in l.min -1 is then given by FE -CO 2 x V . F/(0.67 + 3.43 x Hb/13.3), where Hb equals the patient's haemoglobin in g.dl -1 , and of the 4 ml.dl -1 of CO 2 content difference, 0.67 ml.dl -1 is the proportion derived from plasma and 3.43 dl -1 is the proportion derived from Hb. As the plasma component is small (17%), if this was ignored, a simplified value for Q . could be obtained giving us a third series of estimates with Q . = Q . 1 x 13.33/Hb.
RESULTS
The result from 28 measurements of cardiac output in nine patients with respective methods using 1. V . CO 2 alone, 2. V . CO 2 ,Hb and plasma CO 2 content difference and 3. a simplified method using V . CO 2 and Hb alone, are shown in Table 1 .
They may be summarized as follows. With thermodilution measurements the respective results yielded a correlation coefficient r = 0.91, 0.94 and 0.94 (R 2 = 0.83, 0.88 and 0.88) with a bias of -10%, -0.5% and -0.5% and accuracy of 14%, 8.8% and 8.8%. The mean Hb in this study was 11.86 g.dl -1 . There was almost no difference between the results of methods 2 and 3 (Figure 4) .
Graphical illustration of the results of all three methods are shown in Figure 4 . A Bland-Altman plot comparing the thermodilution method with that of method 2 is shown in Figure 5 .
DISCUSSION
The use of V . CO 2 to indicate cardiac output has been in use for some years and has been found to be extremely valuable, especially when assessing the effectiveness of resuscitative measures 11, 12 . However, the use of the Maxima system greatly simplifies the accurate measurement of V . CO 2 . This requires a steady state for CO 2 homeostasis. This is rapidly 3 : The relation of CO 2 partial pressure difference to CO 2 content difference in blood which is 100% saturated and in blood in the pulmonary vasculature where the respective pulmonary arterial and venous blood is 70% and 100% saturated with a haemoglobin of 13.33 g.dl -1 .
achieved by adjusting V . F to ensure that the FE -CO 2 value stays constant. As the average Hb in this study was 11.86 g.dl -1 , which is about 11% below the chosen normal value of 13.3 g.dl -1 , the cardiac output based on V . CO 2 alone was biased by -10%. The estimate of cardiac output was improved by the use of V . CO 2 combined with the measurement of Hb. The respective accuracy and correlation of the estimates with thermodilution measurements were improved from 14% and coefficient R 2 = 0.83 (r 2 = 0.91) with the use of V . CO 2 alone to 8.8% and coefficient R 2 = 0.88 (r = 0.94) when Hb was taken into consideration both in method 2 and simplified method 3. This degree of correlation is the same as that obtained in a study on five pentobarbital-anaesthetized dogs in which endtidal CO 2 was used to estimate cardiac output (r = 0.94) 12 . However, this excellent correlation may not be a true reflection of reality as the range of cardiac outputs encountered in the study is large. Correlation of values above and below a cardiac output of 6 l.min -1 gave r 2 values of 0.5 and 0.72 respectively.
Although the accuracy of these estimates can only be claimed as being applicable to the conditions described in the present study, they did include two widely differing physiological scenarios; namely, anaesthesia and patients with septicaemia in the intensive care unit. How extensively and reliably this may be applied is yet to be determined. Nevertheless, its potential usefulness in the intensive care unit, as well as the operating room, is demonstrated here. Despite the fact that the method assumes a constant value for the third and most difficult to measure component in the Fick equation, P a CO 2 -P v CO 2 , it would appear to be sufficiently accurate and reliable for clinical purposes and should, at the least, enable clinicians to reliably follow trends.
The delivery of CO 2 into the functional residual capacity (FRC) of the lung is totally dependent upon cardiac output. The main assumption in the proposed method, however, is that homeostatic mechanisms ensure that P a CO 2 -P v CO 2 is held constant in such a way as to maintain C a CO 2 -C v CO 2 at 4.1 ml.dl -1 x 13.3/Hb. This may appear to be a large assumption, nevertheless the same factors which cause cardiac output to rise or fall produce similar changes in tissue 27 
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Anaesthesia and Intensive Care, Vol. 25, No. 1, February 1997 production of CO 2 . C a CO 2 -C v CO 2 is directly affected by haemoglobin because of its role in the carbamino carriage of CO 2 . What is surprising in this study is how workable the apparent oversimplification of method 3 is, where Q . = Q . 1 x 13.3/Hb. To improve the above method will require great accuracy in determining P a CO 2 -P v CO 2 . From Figure  3 , when C a CO 2 -C v CO 2 is equal to 4 ml.dl -1 , P a CO 2 -P v CO 2 is equal to 0.44 kPa only. If there is a future potential to obtain the required accuracy for enhancing the present method, it is likely to come from CO 2 readings of the expired gases. However, the end-tidal CO 2 readings are influenced by functional residual capacity and alveolar deadspace.
While changes in end-tidal CO 2 using a functional non-rebreathing system, such as the circle system, may exaggerate the changes in cardiac output, monitoring FE -CO 2 in the exhaust limb of the Maxima system will not. The reason that end-tidal CO 2 may exaggerate changes in cardiac output in the case of the circle system or any non-rebreathing system is that endtidal CO 2 is not only influenced by V . CO 2 , but also by the changes in physiological deadspace, which is affected by changes in cardiac output 12 . In contrast, the FE -CO 2 value in the Maxima system during rebreathing is influenced only by the V . CO 2 and the set value of V . F. The continuous monitoring of FE -CO 2 is more useful for obtaining cardiac output measurements than end-tidal CO 2 because it accurately follows the changes in cardiac output, whereas endtidal CO 2 is affected by a number of other influences. Not only does end-tidal CO 2 exaggerate the changes in cardiac output due to changes in physiological deadspace, but it is also influenced by all the factors which may cause a variation in tidal volume and minute ventilation.
Given an anaesthesia machine with a capnograph as a routine monitor in place, the only additional expense involved in obtaining a measurement of cardiac output by the proposed method is that of a disposible Maxima breathing system. The method is simple and requires only three rules to be followed, if large errors are to be avoided: 1. adequacy of ventilation, confirmed by a pattern of CO 2 in the distal exhaust limb which varies less than 0.4%; 2. an acute steady state should be maintained, i.e. FE -CO 2 should be steady; 3. V . F should be adjusted to achieve an FE -CO 2 partial pressure value of 4.1 kPa. Cardiac output is then equal to V . F multiplied by the adjustment for haemoglobin, i.e. V . F x 13.33/Hb. Of course, any desired FE -CO 2 value could be used, if it is understood, when calculating Q . , that the relation between FE -CO 2 and V . F is inverse. To obtain greater accuracy in estimating cardiac output will require a lot more effort in obtaining reliable estimates of the third variable in the Fick equation, namely P a CO 2 -P v CO 2 .
The Maxima system, as a rebreathing system, lends itself to the possibility of obtaining an estimate of these values from sampling expired gases during rebreathing ventilation manoeuvres. It remains to be seen if the additional effort in obtaining this value in the pursuit of a reliable, accurate, non-invasive cardiac output measurement will yield a result that is significantly better than is obtained in this study and one that could compare favourably in terms of accuracy with measurements obtained by means of thermodilution techniques.
In conclusion, the Maxima breathing system allows us to measure V . CO 2 in terms of the V . F requirements to achieve a FE -CO 2 value of 4.1 kPa. These requirements would appear to equal pulmonary blood flow.
